(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

MODULADORES DA EXPRESSÃO DE IRF5

ArquivadaInvention PatentPCT · US2019061629

Application data

Number

112021008967

Type

Invention Patent

Filing

11/15/2019

Publication

08/17/2021

PCT

US2019061629

Progress at the INPI

  1. Filing11/15/19
  2. Publication08/17/21
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 11/15/2019 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 05/16/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

IONIS PHARMACEUTICALS, INC.

US

See this company's full portfolio

Inventors

S. F. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

62/767,615 · 11/15/2018

Abstract

MODULADORES DA EXPRESSÃO DE IRF5.A presente invenção refere-se a métodos, compostos e composições úteis para inibir a expressão de IRF5, que podem ser úteis para tratar, prevenir ou aliviar uma doença associada a IRF5.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

05/16/2023

RPI 2732

Arquivamento - Art. 33 da LPI

#11.1

02/28/2023

RPI 2721

Notificação de entrada na fase nacional - PCT

#1.3

08/17/2021

RPI 2641

Alteração de dados cadastrais

#1.1

05/18/2021

RPI 2628

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.